Suchergebnisse - "Curtin, Nicola"

PubPharm (127)

51

The Use of PARP Inhibitors in Cancer Therapy : Use as Adjuvant with Chemotherapy or Radiotherapy, Use as a Single Agent in Susceptible Patients, and Techniques Used to Identify Susceptible Patients

enthalten in: Methods in molecular biology (Clifton, N.J.) | 2017

von Shall, S. | Gaymes, T. | Farzaneh, F. | +2

52

Imagestream detection and characterisation of circulating tumour cells - A liquid biopsy for hepatocellular carcinoma?

enthalten in: Journal of hepatology | 2016

von Ogle, L. | Orr, J. | Willoughby, C. | +7

53

Advanced Ovarian Cancer Displays Functional Intratumor Heterogeneity That Correlates to Ex Vivo Drug Sensitivity

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2016

von O'Donnell, R. | Kaufmann, A. | Woodhouse, L. | +4

54

Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer

enthalten in: British journal of cancer | 2016

von Drew, Y. | Ledermann, J. | Hall, G. | +14

ErratumFor: Br J Cancer. 2016 Mar 29;114(7):723-30. - PMID 27002934

55

Poly(ADP-Ribose) Polymerase in Cervical Cancer Pathogenesis : Mechanism and Potential Role for PARP Inhibitors

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2016

von Kotsopoulos, I. | Kucukmetin, A. | Mukhopadhyay, A. | +2

56

The differential impact of discrimination on health among Black and White women

enthalten in: Social science research | 2016

von Versey, H. | Curtin, N.

57

Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer

enthalten in: British journal of cancer | 2016

von Drew, Y. | Ledermann, J. | Hall, G. | +14

CommentIn: Br J Cancer. 2016 Mar 29;114(7):713-5. - PMID 27022824

58

Chk1 phosphorylated at serine345 is a predictor of early local recurrence and radio-resistance in breast cancer

enthalten in: Molecular oncology | 2016

von Alsubhi, N. | Middleton, F. | Abdel-Fatah, T. | +12

59

mTORC1 and DNA-PKcs as novel molecular determinants of sensitivity to Chk1 inhibition

enthalten in: Molecular oncology | 2016

von Massey, A. | Stephens, P. | Rawlinson, R. | +3

60

High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers

enthalten in: International journal of cancer | 2016

von Dent, B. | Ogle, L. | O'Donnell, R. | +9